Martin Welschof

Chief Executive Officer at BIOINVENT INTERNATIONAL AB

Net worth: 53 145 $ as of 30/08/2026

65 year

74 connections

Health Technology

Commercial Services

Consumer Services

Profile

Martin Welschof was the founder of Affitech AS, founded in 1997, and Affitech A, founded in 2003, where the title of Chief Executive Officer was held from 2003 to 2009.
Current jobs include Chief Executive Officer at BioInvent International AB since 2018, Director at Anocca AB, Director at Uni Targeting Research AS since 2007, Director at Nextera AS since 2013, and Director at APIM Therapeutics AS since 2015.
Former jobs include Chief Executive Officer at Opsona Therapeutics Ltd. from 2012 to 2018, Technology Director at Axaron Bioscience AG from 1997 to 2002, Director at ExpreS2ion Biotechnologies ApS, Director at Zelluna Immunotherapy AS, and Principal at Lynx Therapeutics, Inc. Education includes a doctorate from the University of Bielefeld, conferred in 1996.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BIOINVENT INTERNATIONAL AB 0.03%	30/12/2025	22,400 ( 0.03% )	53 145 $	30/08/2026

Martin Welschof active positions

Companies	Position	Start
BIOINVENT INTERNATIONAL AB	Chief Executive Officer	31/08/2018
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Director/Board Member	31/12/2012
Uni Targeting Research AS Uni Targeting Research AS BiotechnologyHealth Technology Provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures	Director/Board Member	31/12/2006
APIM Therapeutics AS APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology Develops and commercializes novel anti-cancer therapies	Director/Board Member	31/05/2015
Anocca AB Anocca AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company developing next-generation immunotherapies	Director/Board Member	-

All active positions of Martin Welschof

Former positions of Martin Welschof

Companies	Position	End
Opsona Therapeutics Ltd. Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases	Chief Executive Officer	30/06/2018
Affitech AS /Old/ Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Discovers and develops human therapeutic antibodies	Founder	14/06/2009
Affitech A/S Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics	Chief Executive Officer	31/12/2008
Axaron Bioscience AG Axaron Bioscience AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies	Chief Tech/Sci/R&D Officer	31/12/2001
░░░░░░░ ░░░░░░░░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Martin Welschof's experience

Training of Martin Welschof

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Welschof's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	13
Lynx Therapeutics, Inc. Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries	Health Technology
BioInvent International AB BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment	Health Technology
Affitech AS /Old/ Affitech AS /Old/ Miscellaneous Commercial ServicesCommercial Services Discovers and develops human therapeutic antibodies	Commercial Services
University of Bielefeld University of Bielefeld Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Uni Targeting Research AS Uni Targeting Research AS BiotechnologyHealth Technology Provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures	Health Technology
Opsona Therapeutics Ltd. Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases	Health Technology
Affitech A/S Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics	Health Technology
Axaron Bioscience AG Axaron Bioscience AG Miscellaneous Commercial ServicesCommercial Services Develops biotechnologies	Commercial Services
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Commercial Services
APIM Therapeutics AS APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology Develops and commercializes novel anti-cancer therapies	Health Technology
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Health Technology
Zelluna Immunotherapy AS Zelluna Immunotherapy AS BiotechnologyHealth Technology Engages in development of off the shelf T-cell receptor natural killer cell therapies	Health Technology
Anocca AB Anocca AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company developing next-generation immunotherapies	Commercial Services